This Biotech 60%. Healthcare Stocks See Fresh $11M Bet
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Choosing between a Sep Ira and a Simple Ira can be challenging. Discover the key factors to consider for your retirement savings strategy.
15,615 articlesA top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
A top exec recently sold a sizable block of Freshpet shares. This article breaks down what insider selling means, how...
Pension funds are aggressively loading up on the Vanguard Intermediate-Term Government Bond ETF, a move that highligh...
Crypto development is a high-stakes battleground for malware. This article explains how a perplexity built tool that ...
The Janus Henderson AAA CLO ETF draws buyers with a high yield and AAA label, but a hidden tail-risk dynamic could er...
Shark Tank star Kevin O’Leary renews a controversial stance on work-life balance, saying employees who seek rigid hou...
A lot of beaten-down SaaS names have bounced recently. This guide explains how to tell if the rise this beaten-down s...
Ethereum traders face a split view: a potential massive $20k bull market could unfold in the next cycle, but a breach...
A former Goldman Sachs analyst, dismissed as a poor fit, pivots to real estate to build a multi-billion-dollar empire...
When markets tumble, some dividend stocks stand out as thoughtful buys. This article explains how to spot a truly res...
Meta Platforms surprised the market on Wednesday as investors rallied around news of new paid tier options and a broa...
The Strategic Petroleum Reserve sits near a 40-year low, yet Wall Street focuses on production and demand signals rat...